Published articles & abstracts Archive

EV-encapsulated small molecule inhibitor decreases viability in cancer cell lines

Published: 1 May 2018

Document: EV-encapsulated small molecule inhibitor decreases viability in cancer cell lines

Authors: Eleana Hatzidaki, Ioanna Vlachou, Maria Papadimitriou, Ioannis Papasotiriou

Read article

Flow cytometric analysis of CTCs in breast cancer patients before and after chemotherapy

Published: 1 April 2018

Document: Flow cytometric analysis of CTCs in breast cancer patients before and after chemotherapy

Authors: Ntanovasilis D.A., Papasotiriou I.

Read article

CTCs contribution in cancer therapy and progression

Published: 1 March 2018

Document: CTCs contribution in cancer therapy and progression

Authors: Yamaguchi N.H., Barreto C.M.N., Oliveira P.B.T., Manfrinato M.F.G., Silvério F.S., Spada M.T.A., Santos A.S., da Silva A.Q.C., Yasksic M.S., Ntanovasilis D., Apostolou P., Papasotiriou I.

Read article

Evaluation of a simple method for storage of blood samples that enables isolation of circulating tumor cells 96 h after sample collection

Published: 1 September 2017

Document: Evaluation of a simple method for storage of blood samples that enables isolation of circulating tumor cells 96 h after sample collection

Authors: Panagiotis Apostolou, Dimitrios-Athanasios Ntanovasilis and Ioannis Papasotiriou

Read article

Detection and identification of bacterial contamination in blood samples from cancer patients

Published: 1 May 2017

Document: Detection and Identification of Bacterial Contamination in Blood Samples from Cancer Patients

Authors: Katerina Pantopikou, Ioannis Papasotiriou

Read article

Current perspectives on CHEK2 mutations in breast cancer

Published: 1 May 2017

Document: Current perspectives on CHEK2 mutations in breast cancer

Authors: Panagiotis Apostolou, Ioannis Papasotiriou

Read article

Stemness Gene Profiles of Circulating Tumor Cells

Published: 1 February 2017

Document: Stemness Gene Profiles of Circulating Tumor Cells

Authors: Panagiotis Apostolou, Maria Papadimitriou, Ioannis Papasotiriou

Read article

L1 retrotransposon expression in circulating tumor cells

Published: 1 February 2017

Document: L1 retrotransposon expression in CTCs

Authors: Ioannis Papasotiriou, Katerina Pantopikou and Panagiotis Apostolou

Read article

Comparative study of L1 between lung cancer and healthy samples

Published: 29 September 2017

Document: Comparative study of L1 between lung cancer and healthy samples

Authors: Pantopikou K. Apostolou P. Papasotiriou I.

Read article

The molecular profile of colon cancer cells

Published: 28 June 2017

Document: The molecular profile of colon cancer cells

Authors: Apostolou P., Ntanovasilis D., Papadimitriou M., Hatzidaki E., Pantopikou K., Parsonidis P., Papasotiriou I.

Read article

Comparison of genomic and gene expression profile between cancer and healthy samples

Published: 2 June 2017

Document: Comparison of genomic and gene expression profile between cancer and healthy samples

Authors: Ioannis Papasotiriou, Dimitrios Ntanovasilis, Panagiotis Apostolou

Read article

Generation of Human Antibodies Against a Specific Peptide: a Novel Strategy Based on Human Cells

Published: 1 September 2016

Document: Generation of Human Antibodies Against a Specific Peptide: a Novel Strategy Based on Human Cells

Authors: Maria Toloudi, Maria Papadimitriou, Katerina Pantopikou And Ioannis Papasotiriou

Read article

Published articles & abstracts

EV-encapsulated small molecule inhibitor decreases viability in cancer cell lines

Flow cytometric analysis of CTCs in breast cancer patients before and after chemotherapy

CTCs contribution in cancer therapy and progression

Evaluation of a simple method for storage of blood samples that enables isolation of circulating tumor cells 96 h after sample collection

Detection and identification of bacterial contamination in blood samples from cancer patients

Current perspectives on CHEK2 mutations in breast cancer

Stemness Gene Profiles of Circulating Tumor Cells

L1 retrotransposon expression in circulating tumor cells

Comparative study of L1 between lung cancer and healthy samples

The molecular profile of colon cancer cells

Comparison of genomic and gene expression profile between cancer and healthy samples

Generation of Human Antibodies Against a Specific Peptide: a Novel Strategy Based on Human Cells

Need help?

Will you send me the results directly?

Do I need to go through my GP to get a test?

Can RGCC test for BRAF drugs?

Can the Oncotrace test differentiate between benign and malignant tumour cells?

I have a patient whose specific tumour appears to have resisting populations because of the overexpression of the MDR1 gene. This can be reversed by the use of inhibitors of ABG2 pumps. What do I do?

Global Presence

EV-encapsulated small molecule inhibitor decreases viability in cancer cell lines

Flow cytometric analysis of CTCs in breast cancer patients before and after chemotherapy

CTCs contribution in cancer therapy and progression

Evaluation of a simple method for storage of blood samples that enables isolation of circulating tumor cells 96 h after sample collection

Detection and identification of bacterial contamination in blood samples from cancer patients

Current perspectives on CHEK2 mutations in breast cancer

Stemness Gene Profiles of Circulating Tumor Cells

L1 retrotransposon expression in circulating tumor cells

Comparative study of L1 between lung cancer and healthy samples

The molecular profile of colon cancer cells

Comparison of genomic and gene expression profile between cancer and healthy samples

Generation of Human Antibodies Against a Specific Peptide: a Novel Strategy Based on Human Cells

Need help?

Will you send me the results directly?

Do I need to go through my GP to get a test?

Can RGCC test for BRAF drugs?

Can the Oncotrace test differentiate between benign and malignant tumour cells?

I have a patient whose specific tumour appears to have resisting populations because of the overexpression of the MDR1 gene. This can be reversed by the use of inhibitors of ABG2 pumps. What do I do?

Global Presence

Cookies